Early research (Phase 1)Study completedNCT06090799
What this trial is testing
Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects
Who this might be right for
Prevention of Graft Rejection After Organ Transplantation
Guangdong Hengrui Pharmaceutical Co., Ltd 6